Table 1 Correlation analyses of HMGB3/hTERT protein expression in relation to clinicopathologic variables of 119 cervical cancer patients
From: Targeting HMGB3/hTERT axis for radioresistance in cervical cancer
| Characteristic | HMGB3 | P | hTERT | P | ||
|---|---|---|---|---|---|---|
| High | Low | High | Low | |||
| Age | 0.06 | 0.07 | ||||
| ≤ 56 | 23 | 42 | 39 | 26 | ||
| > 56 | 38 | 16 | 42 | 12 | ||
| Pathology | 0.184 | 0.088 | ||||
| CIN III | 8 | 10 | 8 | 10 | ||
| CSCC | 61 | 31 | 65 | 27 | ||
| AUC | 3 | 0 | 3 | 0 | ||
| mixed | 3 | 2 | 4 | 1 | ||
| Differentiation | 0.027 | 0.456 | ||||
| High | 5 | 1 | 5 | 1 | ||
| Middle | 10 | 12 | 13 | 8 | ||
| Low | 53 | 20 | 54 | 19 | ||
| T | 4.21 × 10−8 | 2.51 × 10−7 | ||||
| T1 | 27 | 40 | 31 | 36 | ||
| T2 | 26 | 3 | 27 | 2 | ||
| T3-T4 | 23 | 0 | 23 | 0 | ||
| N | 0.0001 | 0.0004 | ||||
| N0 | 54 | 43 | 59 | 38 | ||
| N1 | 22 | 0 | 22 | 0 | ||
| stage | 4.21 × 10−8 | 2.51 × 10−7 | ||||
| I | 27 | 40 | 31 | 36 | ||
| II | 26 | 3 | 27 | 2 | ||
| III-IV | 23 | 0 | 23 | 0 | ||
